Dáil Éireann Debate, Tuesday - 26 July 2022
1907. Deputy Róisín Shortall asked the Minister for Health the engagements he has had with a company (details supplied) regarding the opening of a hospital abroad; if funding was provided by the HSE to open this facility; and if he will make a statement on the matter. [41201/22]
View answerThe EU Cross Border Directive (CBD) 2011/24/EU provides rules for the reimbursement to patients of the cost of receiving treatment abroad, where the patient would be entitled to such treatment in their home Member State, and supplements the rights that patients already have at EU level. The CBD enables persons resident in the State to access and be reimbursed for healthcare in another Member State by the HSE, provided such healthcare is publicly available within Ireland.
The patient is responsible for paying the provider of the treatment and claiming a reimbursement.
The HSE is responsible for the operation of the Cross-Border Directive and under the terms of the Directive there is a National Contact Point (NCP) in each Member State. The NCP for Ireland is located within the HSE's CBD Office and I have ask the HSE to respond directly to the Deputy on the query raised.
